Equity
€1.2m ▼ 7.3%
LIMON paid out €338,735 in dividends. That is 138% of the 2025 profit.
LIMON
Lifetime
19 annual accounts with figures on one time axis, 22 filings since 2004peak €355,601 (2025)
€355,601▲ 16.2%
peak €245,156 (2025)
€245,156▲ 3.7%
peak €1.3m (2024)
€1.2m▼ 7.3%
€471,286▲ 312%
peak 0.4 FTE (2020)
-not published
Board1 name since 2021
1 director
Documentsfilings and deeds
24-06-202637 days before the deadline
2025micro format
Gross margin from €306,115 to €355,601Dividend €338,735Debts from €114,295 to €471,286Cash from €414,762 to €208,280
Key points
from the 2025 annual accountsTurnover
≈ €540,000 estimated
The micro format states no turnover.
Debts
€471,286 ▲ 312%
Debts rose by €356,991 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.
Liquidity
3.42 was 11.70 in 2024
Short-term debts rose from €114,295 to €471,286.
Filings
22 annual accounts since 2004
Five of the last ten came late. The 2019 accounts came latest: 75 days after the end of the period.
Position in the sector
€1.2m
More equity than 95% of companies in human health. Sector median €125,064 · 21,313 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 31,356 companies had the same profile as LIMON has now. Each dot stands for 79 companies, two years later.
93.5%
were still trading
5.9%
stopped another way
0.5%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 31,356 companies, not a prediction for LIMON. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0479777341
Company renamed from DOKTER to LIMON
“Het ereloon betreffende de geneeskundige prestaties van de vennoten wordt geïnd door en voor rekening van de…” (deed in Dutch) · General meeting of 20-09-2023 · Gazette deed
First establishment
BVBA Dokter , Drie Eikenstraat 84, Edegem
Incorporation
published on 21-03-2003 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| LIMON Edegem | €1.7m | €355,601 | 71.6% | - |
| Dokters Buelens - Clerckx Lier | €1.7m | €370,031 | 99.6% | 0 |
| DR.COREMANS EN DR. NOWÉ Willebroek | €1.8m | €357,747 | 90.5% | - |
| ANURO Schilde | €1.7m | €367,404 | 85.4% | - |
| DR. JAN VAN HAESENDONCK Lier | €1.5m | €336,572 | 89.9% | - |
| DR. K. MEERSSCHAERT, anesthesist Mol | €1.5m | €326,675 | 99.2% | - |
| Dokter Ann Aerts Westerlo | €1.6m | €401,989 | 89.3% | - |
These companies have the same main activity as LIMON: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.5m and €1.8m, founded between 2003 and 2005.
Official details
Source: KBO- Status
- Active since 13-03-2003Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.292.029.1332650 Edegem, since 01-10-2018
- Financial year end
- 31 December
- Peppol
- Reachable since 09-07-2025
Annual accounts 2025
- €1.7m▲ 18.9%
- Employeeson 31-12-2025
- 1=
- Filing
- Filed on 24-06-2026, 37 days before the end of the filing period
Insights on LIMON
LIMON files the micro format. That format states no turnover. The gross margin rose from €104,531 in 2007 to €355,601 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about LIMON
- What is the company number of LIMON?
- The company number of LIMON is 0479.777.341. The VAT number is the same number with BE in front: BE 0479.777.341.
- Where is LIMON based?
- The registered office is at Drie Eikenstraat 84, 2650 Edegem.Company details
- What does LIMON do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of LIMON?
- LIMON is a private limited company (BV).
- When was LIMON founded?
- LIMON was founded on 13-03-2003.
- Is LIMON still active?
- Yes, LIMON is an active enterprise in the KBO register.
- How many employees does LIMON have?
- LIMON had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of LIMON?
- The turnover in financial year 2025 is ≈ €540,000. This figure is estimated from the gross margin of €355,601 and 30 comparable companies (NACE 86220). It probably lies between €480,000 and €740,000.
- Is LIMON profitable?
- In financial year 2025, LIMON made a profit of €245,156.
- Where can I find the annual accounts of LIMON?
- LIMON filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of LIMON due?
- LIMON must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.